<DOC>
	<DOCNO>NCT01251016</DOCNO>
	<brief_summary>Type 2 diabetes mellitus ( T2DM ) relevant public health problem obesity associate major risk factor . Roux-en-Y gastric bypass effective method treat severe obesity , metabolic benefit lead early complete remission T2DM , even considerable weight loss . We hypothesize intestinal anatomic change may change intestinal gene expression relate glycemic control . The knowledge mechanism mediate glycemic control Roux-en-Y gastric bypass site action bowel may eventually help develop alternative , less invasive safer surgery treatment T2DM , well drug development newly target identify .</brief_summary>
	<brief_title>Effect Bariatric Surgery Gut Hormones Production Cure Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetes mellitus ( T2DM ) diagnosis Duration T2DM &gt; 5 year Use oral antidiabetic agent Body Mass Index &gt; 40 kg/m2 Candidates RouxenY gastric bypass Type 1 diabetes mellitus nondiabetics Use insulin Thyroid diseases Candidate surgery technique Body Mass Index &lt; 40 kg/m2 Presence bacterium H. Pylori</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Y-Roux gastric bypass</keyword>
	<keyword>Gut hormone</keyword>
	<keyword>Gene expression</keyword>
	<keyword>Surgery</keyword>
</DOC>